|
EIF2S2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.79450000034909E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.93199999998228E-06 |
| Normal-vs-Stage2 |
2.394100E-02 |
| Normal-vs-Stage3 |
2.659900E-03 |
| Normal-vs-Stage4 |
4.735400E-03 |
| Stage1-vs-Stage2 |
8.768800E-01 |
| Stage1-vs-Stage3 |
2.864000E-01 |
| Stage1-vs-Stage4 |
7.453600E-01 |
| Stage2-vs-Stage3 |
6.397800E-01 |
| Stage2-vs-Stage4 |
7.299000E-01 |
| Stage3-vs-Stage4 |
3.495000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.28009999999612E-05 |
| Normal-vs-AfricanAmerican |
6.064800E-03 |
| Normal-vs-Asian |
1.744920E-03 |
| Caucasian-vs-AfricanAmerican |
6.202400E-01 |
| Caucasian-vs-Asian |
4.005200E-01 |
| AfricanAmerican-vs-Asian |
8.953600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.139700E-03 |
| Normal-vs-Female |
1.49220000023043E-07 |
| Male-vs-Female |
1.184430E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.73689999996662E-06 |
| Normal-vs-Age(41-60Yrs) |
1.602080E-03 |
| Normal-vs-Age(61-80Yrs) |
2.079800E-03 |
| Normal-vs-Age(81-100Yrs) |
2.397700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.006810E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.965400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.110200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.919400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.685400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.298000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.936800E-01 |
| Classical-VS-Follicular |
6.008000E-01 |
| Classical-VS-Other |
1.136160E-01 |
| Classical-VS-Normal |
8.89769999901091E-08 |
| Tall-VS-Follicular |
7.801200E-01 |
| Tall-VS-Other |
1.584450E-01 |
| Tall-VS-Normal |
1.021600E-02 |
| Follicular-VS-Other |
3.843400E-01 |
| Follicular-VS-Normal |
1.913720E-02 |
| Other-VS-Normal |
8.724000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.33860000000186E-05 |
| Normal-vs-N1 |
2.028200E-01 |
| N0-vs-N1 |
2.003800E-01 |
|
|
